Nectin cell adhesion molecule-4 (NECTIN-4): A potential target for cancer therapy

被引:63
作者
Chatterjee, Subhajit [1 ]
Sinha, Saptarshi [1 ]
Kundu, Chanakya Nath [1 ]
机构
[1] Deemed Univ, Kalinga Inst Ind Technol KIIT, Sch Biotechnol, Canc Biol Div, Campus 11, Bhubaneswar 751024, Odisha, India
关键词
Nectin-4; Cancer; Cancer stemness; Angiogenesis; Metastasis; Therapeutic strategies; VEDOTIN PLUS PEMBROLIZUMAB; ENFORTUMAB VEDOTIN; MEASLES-VIRUS; TRANS-INTERACTIONS; PROGNOSTIC ROLE; PHASE-III; V-DOMAIN; C-SRC; EXPRESSION; RECEPTOR;
D O I
10.1016/j.ejphar.2021.174516
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
NECTIN-4 [a poliovirus receptor-related-4 (pvrl-4) encoded protein] is a Ca2+ independent immunoglobulin-like protein. Along with other Nectins (Nectin-1, -2 and -3), it is primarily involved in cell-cell adhesion. In contrast to other Nectins, Nectin-4 is specifically enriched in the embryonic and placental tissues but its expression significantly declines in adult life. In recent years, it has been found that Nectin-4 is especially overexpressed and served as a tumor associated inducer in various malignant tumors including breast, lung, colorectal, pancreatic, ovarian cancers etc. Over-expression of Nectin-4 is associated with various aspects of tumor progression like proliferation, angiogenesis, epithelial to mesenchymal transition, metastasis, DNA repair, tumor relapse, poor prognosis in several types of cancer. This review systematically highlights the implications of Nectin-4 in every possible aspect of cancer and the molecular mechanism of Nectin-4 mediated cancer progression. We have further emphasized on the therapeutic strategies that are being proposed to specifically target Nectin-4.
引用
收藏
页数:20
相关论文
共 88 条
[1]   The significance of Survivin and Nectin-4 expression in the prognosis of breast carcinoma [J].
Athanassiadou, Anna Maria ;
Patsouris, Efstratios ;
Tsipis, Angelos ;
Gonidi, Maria ;
Athanassiadou, Pauline .
FOLIA HISTOCHEMICA ET CYTOBIOLOGICA, 2011, 49 (01) :26-33
[2]   Targeted Molecular Therapeutics for Bladder Cancer-A New Option beyond the Mixed Fortunes of Immune Checkpoint Inhibitors? [J].
Bednova, Olga ;
Leyton, Jeffrey V. .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (19) :1-25
[3]   NECTIN4 (PVRL4) as Putative Therapeutic Target for a Specific Subtype of High Grade Serous Ovarian Cancer-An Integrative Multi-Omics Approach [J].
Bekos, Christine ;
Muqaku, Besnik ;
Dekan, Sabine ;
Horvat, Reinhard ;
Polterauer, Stephan ;
Gerner, Christopher ;
Aust, Stefanie ;
Pils, Dietmar .
CANCERS, 2019, 11 (05)
[4]  
BLUMING AZ, 1971, LANCET, V2, P105
[5]   Nectin-1 Binds and Signals through the Fibroblast Growth Factor Receptor [J].
Bojesen, Kirsten B. ;
Clausen, Ole ;
Rohde, Kristian ;
Christensen, Claus ;
Zhang, Lanjun ;
Li, Shizhong ;
Kohler, Lene ;
Nielbo, Steen ;
Nielsen, Janne ;
Gjorlund, Michelle D. ;
Poulsen, Flemming M. ;
Bock, Elisabeth ;
Berezin, Vladimir .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2012, 287 (44) :37420-37433
[6]   Inhibition of Ovarian Cancer Cell Spheroid Formation by Synthetic Peptides Derived from Nectin-4 [J].
Boylan, Kristin L. M. ;
Manion, Rory D. ;
Shah, Heena ;
Skubitz, Keith M. ;
Skubitz, Amy P. N. .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2020, 21 (13) :1-16
[7]   The expression of Nectin-4 on the surface of ovarian cancer cells alters their ability to adhere, migrate, aggregate, and proliferate [J].
Boylan, Kristin L. M. ;
Buchanan, Petra C. ;
Manion, Rory D. ;
Shukla, Dip M. ;
Braumberger, Kelly ;
Bruggemeyer, Cody ;
Skubitz, Amy P. N. .
ONCOTARGET, 2017, 8 (06) :9717-9738
[8]   Mutations in PVRL4, Encoding Cell Adhesion Molecule Nectin-4, Cause Ectodermal Dysplasia-Syndactyly Syndrome [J].
Brancati, Francesco ;
Fortugno, Paola ;
Bottillo, Irene ;
Lopez, Marc ;
Josselin, Emmanuelle ;
Boudghene-Stambouli, Omar ;
Agolini, Emanuele ;
Bernardini, Laura ;
Bellacchio, Emanuele ;
Iannicelli, Miriam ;
Rossi, Alfredo ;
Dib-Lachachi, Amina ;
Stuppia, Liborio ;
Palka, Giandomenico ;
Mundlos, Stefan ;
Stricker, Sigmar ;
Kornak, Uwe ;
Zambruno, Giovanna ;
Dallapiccola, Bruno .
AMERICAN JOURNAL OF HUMAN GENETICS, 2010, 87 (02) :265-273
[9]  
Bruce JY, 2020, J CLIN ONCOL, V38
[10]   Enfortumab Vedotin Antibody-Drug Conjugate Targeting Nectin-4 Is a Highly Potent Therapeutic Agent in Multiple Preclinical Cancer Models [J].
Challita-Eid, Pia M. ;
Satpayev, Daulet ;
Yang, Peng ;
An, Zili ;
Morrison, Karen ;
Shostak, Yuriy ;
Raitano, Arthur ;
Nadell, Rossana ;
Liu, Wendy ;
Lortie, Dawn Ratay ;
Capo, Linnette ;
Verlinsky, Alla ;
Leavitt, Monica ;
Malik, Faisal ;
Avina, Hector ;
Guevara, Claudia I. ;
Dinh, Nick ;
Karki, Sher ;
Anand, Banmeet S. ;
Pereira, Daniel S. ;
Joseph, Ingrid B. J. ;
Donate, Fernando ;
Morrison, Kendall ;
Stover, David R. .
CANCER RESEARCH, 2016, 76 (10) :3003-3013